Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.52 |
| ▸ | ACHE | P22303 | 7/20 | 0.49 |
| ▸ | BCHE | P06276 | 4/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TNF | P01375 | 1/20 | 0.44 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.43 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2334501 | 0.83 | ALOX5 (0.69) | ALOX5ACHEKMT2A | |
| SCHEMBL2341893 | 0.76 | HIF1A (0.46) | HIF1AACHE | |
| SCHEMBL10693720 | 0.76 | ALOX5 (1.00) | ALOX5KMT2AAKR1C3AKR1C2 | |
| SCHEMBL490870 | 0.75 | TTR (0.56) | ALOX5HIF1AACHEL3MBTL1CA1 | |
| SCHEMBL2336706 | 0.75 | ACHE (0.59) | ALOX5ACHEBCHEL3MBTL1ALDH1A1 | |
| SCHEMBL9115746 | 0.74 | TDP1 (0.63) | ACHEBCHEL3MBTL1MAPT | |
| SCHEMBL28219379 | 0.74 | BCHE (0.48) | ACHEBCHEL3MBTL1MAPTALDH1A1 | |
| SCHEMBL490776 | 0.74 | ACHE (0.61) | HIF1AACHEL3MBTL1CA1CA2 | |
| SCHEMBL14032691 | 0.74 | ACHE (0.61) | HIF1AACHEL3MBTL1CA1CA2 | |
| SCHEMBL5122373 | 0.74 | ACHE (0.61) | HIF1AACHEL3MBTL1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9210928-B2 | Plant development control composition | SYNGENTA CROP PROTECTION, LLC (US) | 2015-12-15 | — | — | US | disclosed |
| US-20110301028-A1 | PLANT DEVELOPMENT CONTROL COMPOSITION | SYNGENTA CROP PROTECTION, LLC (US) | 2011-12-08 | — | — | US | disclosed |
| EP-2358197-A2 | PLANT DEVELOPMENT CONTROL COMPOSITION | Syngenta Participations AG (CH) | 2011-08-24 | — | — | EP | disclosed |
| WO-2010055316-A2 | PLANT DEVELOPMENT CONTROL COMPOSITION | THE UNIVERSITY OF WARWICK (GB) | 2010-05-20 | — | — | WO | disclosed |
| WO-2010055310-A1 | HERBICIDAL COMPOSITIONS | THE UNIVERSITY OF WARWICK (GB) | 2010-05-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110301028-A1 | PLANT DEVELOPMENT CONTROL COMPOSITION | MSL1, OXSR1, OSR1 | ALOX5 3171/4885HIF1A 883/4885ACHE 3601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.